#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic mastocytosis Choroidal dystrophy Gestational trophoblastic tumour Wiskott-Aldrich syndrome Antiphospholipid antibodies Cutaneous T-cell lymphoma stage I Brain abscess Retinal artery occlusion Haemophilia Breast angiosarcoma Hepatoblastoma Pancreatic neuroendocrine tumour Isodicentric chromosome 15 syndrome Endometrial cancer Acute promyelocytic leukaemia More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Diagnostics Niemann-Pick disease – Treatment Adrenocortical carcinoma – Trials in Disease Uterine leiomyosarcoma – Basic Information Cholangitis sclerosing – Treatment Progressive multifocal leukoencephalopathy Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Osteosarcoma recurrent – Diagnostics Haemophilia A without inhibitors – Treatment Idiopathic inflammatory myopathy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Isotretinoin AGA2118 Vilobelimab PHENTOLAMINE MESILATE Acetylcholine Chloride L-Lysine Hydrochloride Amifostine Thiol Bi 1839100 Formoterol Fumarate Calcipotriol Sargramostim Bcmacp03 Ravulizumab Teprenone L-METHIONINE Dorocubicel Nicotinamide Gad20-209-Fsp-A3 Delandistrogene Moxeparvovec Alglucosidase Alfa More therapies…

    Learn about Your Condition

    Exudative retinopathy Acromegaly Hypereosinophilic syndrome Rectal neoplasm SAPHO syndrome Colon cancer stage II Axial spondyloarthritis Neurofibromatosis Head injury T-cell lymphoma Muscle injury Respiratory tract infection Niemann-Pick disease Hairy cell leukaemia Lung disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Basal cell carcinoma

  • Testing bifikafusp alfa and onfekafusp alfa injections in patients with locally advanced basal cell carcinoma

    Recruiting

    2 1 1
    Investigated Drugs:
    • Bifikafusp Alfa
    • Onfekafusp Alfa
    Germany Greece Italy Spain

  • Study of bifikafusp alfa and onfekafusp alfa injected into tumors for patients with locally advanced basal cell carcinoma who progressed on or cannot tolerate systemic treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Basal cell carcinoma
    Investigated Drugs:
    • Bifikafusp Alfa
    • Onfekafusp Alfa
    Germany Greece Italy Spain

  • Study of Cemiplimab Combined with Imiquimod and Laser Therapy Before Surgery for High-Risk Skin Basal Cell Carcinoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Basal cell carcinoma
    Investigated Drugs:
    • Imiquimod
    • Cemiplimab
    Spain

  • Study Comparing Electrochemotherapy with Bleomycin to Standard Radiotherapy for Treating Basal Cell Carcinoma in Patients with Tumors Less Than 3 cm

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Basal cell carcinoma
    Investigated Drugs:
    • Bleomycin
    Denmark

  • Evaluation of Cemiplimab Safety and Effectiveness as First Treatment for Advanced Basal Cell Carcinoma in Adult Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cemiplimab
    Germany

  • Study on Tirbanibulin for Treating Superficial Basal Cell Carcinoma in Patients

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Tirbanibulin
    France
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!